KR101137467B1 - 테오브로민 함유 서방성 정제 - Google Patents
테오브로민 함유 서방성 정제 Download PDFInfo
- Publication number
- KR101137467B1 KR101137467B1 KR1020090105137A KR20090105137A KR101137467B1 KR 101137467 B1 KR101137467 B1 KR 101137467B1 KR 1020090105137 A KR1020090105137 A KR 1020090105137A KR 20090105137 A KR20090105137 A KR 20090105137A KR 101137467 B1 KR101137467 B1 KR 101137467B1
- Authority
- KR
- South Korea
- Prior art keywords
- theobromine
- weight
- sustained
- release
- release layer
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090105137A KR101137467B1 (ko) | 2009-11-02 | 2009-11-02 | 테오브로민 함유 서방성 정제 |
RU2012119070/15A RU2506947C2 (ru) | 2009-11-02 | 2010-09-01 | Таблетка пролонгированного высвобождения, содержащая теобромин |
CN201080051266.9A CN102711740B (zh) | 2009-11-02 | 2010-09-01 | 含可可碱的缓释锭剂 |
UAA201206606A UA103558C2 (ru) | 2009-11-02 | 2010-09-01 | Таблетка пролонгированного высвобождения, которая содержит теобромин |
PCT/KR2010/005911 WO2011052884A2 (ko) | 2009-11-02 | 2010-09-01 | 테오브로민 함유 서방성 정제 |
TR2012/05029T TR201205029T1 (tr) | 2009-11-02 | 2010-09-01 | Teobromin içeren yavaş salınımlı tablet. |
BR112012010325A BR112012010325B8 (pt) | 2009-11-02 | 2010-09-01 | comprimido com liberação sustentada e imediata de teobromina |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090105137A KR101137467B1 (ko) | 2009-11-02 | 2009-11-02 | 테오브로민 함유 서방성 정제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110048367A KR20110048367A (ko) | 2011-05-11 |
KR101137467B1 true KR101137467B1 (ko) | 2012-04-20 |
Family
ID=43922740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090105137A KR101137467B1 (ko) | 2009-11-02 | 2009-11-02 | 테오브로민 함유 서방성 정제 |
Country Status (7)
Country | Link |
---|---|
KR (1) | KR101137467B1 (tr) |
CN (1) | CN102711740B (tr) |
BR (1) | BR112012010325B8 (tr) |
RU (1) | RU2506947C2 (tr) |
TR (1) | TR201205029T1 (tr) |
UA (1) | UA103558C2 (tr) |
WO (1) | WO2011052884A2 (tr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101220830B1 (ko) * | 2010-08-18 | 2013-01-10 | 안국약품 주식회사 | 테오브로민의 서방성 과립제 및 그 제조방법 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060113728A (ko) * | 2003-11-13 | 2006-11-02 | 룀 게엠베하 | 조절 물질의 전달에 영향을 미치는 매트릭스를 갖는 다층약제학적 형태 |
KR20070078625A (ko) * | 2006-01-27 | 2007-08-01 | 씨제이 주식회사 | 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070196481A1 (en) * | 2002-07-25 | 2007-08-23 | Amidon Gregory E | Sustained-release tablet composition |
KR20070017335A (ko) * | 2004-03-22 | 2007-02-09 | 노파르티스 아게 | 리카르바제핀을 포함하는 경구투여용 매트릭스 제제 |
KR20070119658A (ko) * | 2005-03-29 | 2007-12-20 | 에보니크 룀 게엠베하 | 활성 성분 방출에 대한 조절 효과를 가지는 물질을포함하는 펠렛을 포함하는 다중 미립자 제약 형태 |
-
2009
- 2009-11-02 KR KR1020090105137A patent/KR101137467B1/ko active IP Right Grant
-
2010
- 2010-09-01 TR TR2012/05029T patent/TR201205029T1/tr unknown
- 2010-09-01 CN CN201080051266.9A patent/CN102711740B/zh not_active Expired - Fee Related
- 2010-09-01 UA UAA201206606A patent/UA103558C2/ru unknown
- 2010-09-01 BR BR112012010325A patent/BR112012010325B8/pt not_active IP Right Cessation
- 2010-09-01 WO PCT/KR2010/005911 patent/WO2011052884A2/ko active Application Filing
- 2010-09-01 RU RU2012119070/15A patent/RU2506947C2/ru active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060113728A (ko) * | 2003-11-13 | 2006-11-02 | 룀 게엠베하 | 조절 물질의 전달에 영향을 미치는 매트릭스를 갖는 다층약제학적 형태 |
KR20070078625A (ko) * | 2006-01-27 | 2007-08-01 | 씨제이 주식회사 | 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
WO2011052884A3 (ko) | 2011-07-14 |
BR112012010325A2 (pt) | 2016-03-29 |
KR20110048367A (ko) | 2011-05-11 |
BR112012010325B1 (pt) | 2021-01-26 |
RU2012119070A (ru) | 2013-12-10 |
CN102711740B (zh) | 2014-02-12 |
TR201205029T1 (tr) | 2012-09-21 |
CN102711740A (zh) | 2012-10-03 |
RU2506947C2 (ru) | 2014-02-20 |
WO2011052884A2 (ko) | 2011-05-05 |
UA103558C2 (ru) | 2013-10-25 |
BR112012010325B8 (pt) | 2021-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101931195B1 (ko) | 올메사탄 메독소밀 및 로수바스타틴 또는 그의 염을 포함하는 약학 조성물 | |
KR101234940B1 (ko) | 안정한 서방출형의 경구 투여용 조성물 | |
KR101465077B1 (ko) | 다폭세틴을 포함하는 시간차 서방출 경구투여형 약학적 조성물 | |
KR100888131B1 (ko) | 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제 | |
KR100780553B1 (ko) | 메트포르민 서방정 및 그의 제조방법 | |
EP2395838B1 (en) | Stable pharmaceutical composition for atherosclerosis | |
KR20090091085A (ko) | 방출성이 제어된 약제학적 제제 | |
KR102246657B1 (ko) | 타다라필 및 탐수로신을 함유하는 약학적 캡슐 복합 제제 | |
KR101272470B1 (ko) | 레보드로프로피진을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물 | |
CA2182004C (en) | Film coated tablet of paracetamol and domperidone | |
KR101455741B1 (ko) | 고형 의약 제제 | |
MX2015004296A (es) | Farmaco combinado que comprende gemigliptina y metformina, y metodo para su preparacion. | |
KR101512386B1 (ko) | 미티글리나이드 및 메트포르민 복합제제 및 그의 제조방법 | |
KR101220829B1 (ko) | 트리메부틴 함유 서방성 정제 | |
KR102294190B1 (ko) | 신규한 용출 파라미터를 이용한 모사프리드 함유 서방제제 | |
KR101414814B1 (ko) | 염산레르카니디핀 및 발사르탄을 포함하는 복합 제제 및 이의 제조방법 | |
KR101137467B1 (ko) | 테오브로민 함유 서방성 정제 | |
CA2624838C (en) | Retard formulation for pralnacasan | |
WO2019132833A1 (en) | The modified release combination comprising linagliptin and metformin | |
KR102376010B1 (ko) | 아스피린 및 티카그렐러를 포함하는 유핵정 복합제제 | |
KR102246066B1 (ko) | 레보드로프로피진 함유 서방정의 제조방법 | |
KR102294186B1 (ko) | 1일 1회 경구투여하는 모사프리드 함유 서방제제 | |
KR102210422B1 (ko) | 신규한 용출 파라미터를 이용한 이토프라이드 함유 서방제제 | |
KR102189191B1 (ko) | 1일 1회 경구투여하는 이토프라이드 염산염 함유 서방제제 | |
KR101591357B1 (ko) | 미티글리나이드 및 메트포르민 복합제제 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160412 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170210 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20190220 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20200218 Year of fee payment: 9 |